Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa.
Open Access
- 1 January 1992
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 267 (2) , 876-882
- https://doi.org/10.1016/s0021-9258(18)48365-2
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Regulation of coagulation by a multivalent Kunitz-type inhibitorBiochemistry, 1990
- Inhibition of Factor VIIa-Tissue Factor Coagulation Activity by a Hybrid ProteinScience, 1990
- Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibodyThrombosis Research, 1990
- Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitorNature, 1989
- Characterization of anti-tissue factor antibody and its use in immunoaffinity purification of human tissue factorThrombosis Research, 1988
- Heparin induces release of extrinsic: Coagulation pathway inhibitor (EPI)Thrombosis Research, 1988
- Human placental anticoagulant protein: isolation and characterizationBiochemistry, 1987
- Phospholipid vesicle formation and transmembrane protein incorporation using octyl glucosideBiochemistry, 1981
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970